U.S. Markets close in 3 hrs 48 mins

Momenta Pharmaceuticals, Inc. (MNTA)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
17.075+0.175 (+1.036%)
As of 12:12PM EDT. Market open.
People also watch
ALNYACORNBIXMDCOVNDA
Full screen
Previous Close16.900
Open16.950
Bid16.950 x 500
Ask17.000 x 1200
Day's Range16.550 - 17.100
52 Week Range10.500 - 19.900
Volume101,922
Avg. Volume822,950
Market Cap1.27B
Beta2.04
PE Ratio (TTM)-40.95
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Capital Cube10 days ago

    ETFs with exposure to Momenta Pharmaceuticals, Inc. : July 10, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Momenta Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to MNTA-US. Comparing the performance and risk of Momenta Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Capital Cube23 days ago

    ETFs with exposure to Momenta Pharmaceuticals, Inc. : June 27, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Momenta Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to MNTA-US. Comparing the performance and risk of Momenta Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Mylan In FDA Limbo On Generic Multiple Sclerosis Drug
    Investor's Business Dailylast month

    Mylan In FDA Limbo On Generic Multiple Sclerosis Drug

    Mylan stock fell as the FDA is looking for more information into its generic version of the multiple sclerosis drug Copaxone.